2011

• Happell, B., Platania-Phung, C., Gray, R., Hardy, S., Lambert, T., McAllister, M., Davies, C. A role for mental health nursing in the physical health care of consumers with severe mental illness. Journal of Psychiatric and Mental Health Nursing. 2011; 18:706-711. [Abstract]
• Lambert, T., Olivares, J., Peuskens, J., Desouza, C., Kozma, C., Otten, P., Crivera, C., Jacobs, A., Macfadden, W., Mao, L., Rodriguez, S., Dirani, R., Akhras, K. Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium. Annals of General Psychiatry. 2011; 10:10. [Abstract]
• Lambert, T. Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis. Australian Prescriber. 2011; 34:97-99.
• Haddad, P., Lambert, T., Lauriello, J. The role of antipsycholtic long-acting injections in current practice. In: Antipsychotic Long-acting injections. United Kingdom: Oxford University Press 2011. p. 241-260.

2010

• Guastella, A., Einfeld, S., Gray, K., Rinehart, N., Tonge, B., Lambert, T., Hickie, I. Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders. Biological psychiatry. 2010; 67:692-4. [Abstract]
• Lambert, T. Disease Management: MultidimensionalApproaches to Incomplete Recovery inPsychosis. In: Advances in Biological Psychiatry: Therapy-Resistant Schizophrenia. Basel (Switzerland): S. Karger AG, 2010. p. 87-113.
• Lambert, T. Office for Psychiatric Evaluation and New Media (open). In: The Department of Psychiatry at the University of Melbourne 1964-2009: Personal Reminiscences. Australia: University of Melbourne 2010. p. 130-134.

2009

• Lambert, T., Singh, B., Patel, M. Community treatment orders and antipsychotic long-acting injections. British Journal of Psychiatry. 2009; 195:S57-S62. [Abstract]
• Lambert, T. Switching to aripiprazole from olanzapine leads to weight loss in overweight people with schizophrenia or schizoaffective disorder. Evidence - Based Mental Health. 2009; 12:50. [Abstract]
• Lambert, T., Newcomer, J. Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Medical Journal of Australia. 2009; 190:S39-S42. [Abstract]
• Lambert, T. The medical care of people with psychosis. Medical Journal of Australia. 2009; 190:171-172. [Abstract]
• Addington, J., Lambert, T., Burnett, P. Complete and incomplete recovery from first-episode psychosis. In: The Recognition and Management of Early Psychosis: A Preventive Approach. United Kingdom: Cambridge University Press 2009. p. 201-222.

2008

• Walter, G., Delaroche, A., Soh, N., Hunt, G., Cleary, M., Malhi, G., Lambert, T., Correll, C., Rey, J. Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2008; 16:253-62. [Abstract]
• Sundram, S., Lambert, T., Piskulic, D. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Acta psychiatrica Scandinavica. 2008; 117:474-478. [Abstract]
• Lauriello, J., Lambert, T., Andersen, S., Lin, D., Taylor, C., McDonnell, D. An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia. The Journal of clinical psychiatry. 2008; 69:790-9. [Abstract]
• Lambert, T., Norman, T. Ethnic differences in psychotropic drug response and pharmacokinetics. In: Ethno-psychopharmacology: Advances in Current Practice. United Kingdom: Cambridge University Press 2008. p. 38-61.

2007

• Iqbal, N., Lambert, T., Masand, P. Akathisia: problem of history or concern of today. CNS spectrums. 2007; 12:1-13. [Abstract]
• Elsom, S., Happell, B., Manias, E., Lambert, T. Expanded practice roles for community mental health nurses: a qualitative exploration of psychiatrists' views. Australasian Psychiatry. 2007; 15:324-328. [Abstract]
• Subramaniam, M., Ng, C., Chong, S., Mahendran, R., Lambert, T., Pek, E., Huak, C. Metabolic differences between Asian and Caucasian patients on clozapine treatment. Human psychopharmacology. 2007; 22:217-222. [Abstract]
• Berk, M., Fitzsimons, J., Lambert, T., Pantelis, C., Kulkarni, J., Castle, D., Ryan, E., Jespersen, S., McGorry, P., Berger, G., Kuluris, B., Callaly, T., Dodd, S. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS drugs. 2007; 21:117-127. [Abstract]
• Weiden, P., Miller, A., Lambert, T., Buckley, P. The art and science of switching antipsychotic medications, part 2. The Journal of clinical psychiatry. 2007; 68:e02. [Abstract]
• Lambert, T. Switching antipsychotic therapy: what to expect and clinical strategies for improving therapeutic outcomes. The Journal of clinical psychiatry. 2007; 68:10-13. [Abstract]

2006

• Castle, D., Lambert, T., Melbourne, S., Cox, A., Boardman, G., Fairest, K., Davy, M., Goh, J., Kuluris, B., Berk, M. A clinical monitoring system for clozapine. Australasian Psychiatry. 2006; 14:156-168. [Abstract]
• Lambert, T. Selecting patients for long-acting novel antipsychotic therapy. Australasian Psychiatry. 2006; 14:38-42. [Abstract]
• Lambert, T. Atypical antipsychotics in schizophrenia. Medicine Today. 2006; 7:55-58.